PDS Biotechnology Corporation

NASDAQ:PDSB  
2.12
+0.16 (+8.16%)
Earnings Announcements

PDS Biotechnology Reports Q3 Loss Per Share Of $0.23

Published: 11/11/2020 21:26 GMT
PDS Biotechnology Corp (PDSB) - Pds Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update.
Q3 Loss per Share $0.23.
As of September 30, 2020, Co's Cash Balance Was About $33.5 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.19

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.